4-99549174-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001134665.3(TRMT10A):āc.934A>Gā(p.Ser312Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000143 in 1,614,020 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001134665.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRMT10A | NM_001134665.3 | c.934A>G | p.Ser312Gly | missense_variant | 8/8 | ENST00000394876.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRMT10A | ENST00000394876.7 | c.934A>G | p.Ser312Gly | missense_variant | 8/8 | 1 | NM_001134665.3 | P1 | |
TRMT10A | ENST00000273962.7 | c.934A>G | p.Ser312Gly | missense_variant | 8/8 | 1 | P1 | ||
TRMT10A | ENST00000394877.7 | c.934A>G | p.Ser312Gly | missense_variant | 8/8 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251340Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135830
GnomAD4 exome AF: 0.000144 AC: 211AN: 1461832Hom.: 1 Cov.: 31 AF XY: 0.000139 AC XY: 101AN XY: 727218
GnomAD4 genome AF: 0.000125 AC: 19AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 20, 2021 | This sequence change does not appear to have been previously described in patients with TRMT10A-related disorders and has been described in the gnomAD database with a low population frequency of 0.015% in the non-Finnish European subpopulation (dbSNP rs151225187). The p.Ser312Gly change affects a poorly conserved amino acid residue located in a domain of the TRMT10A protein that is not known to be functional. The p.Ser312Gly substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Ser312Gly change remains unknown at this time. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2024 | The c.934A>G (p.S312G) alteration is located in exon 8 (coding exon 7) of the TRMT10A gene. This alteration results from a A to G substitution at nucleotide position 934, causing the serine (S) at amino acid position 312 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 12, 2022 | This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 312 of the TRMT10A protein (p.Ser312Gly). This variant is present in population databases (rs151225187, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with TRMT10A-related conditions. ClinVar contains an entry for this variant (Variation ID: 1338060). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glycine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at